← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Pharmabridge, Inc.
Doylestown, PA
$3,200,094
Total funding
2
Grants
Funding over time
peak $1M · FY2008–13$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$3,200,094 · 2
By mechanism
R44$2,959,948 · 1
R43$240,146 · 1
Investigators at Pharmabridge, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection$1,000,000
R44 · FY2011 · AI
Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection$980,003
R44 · FY2012 · AI
Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection$979,945
R44 · FY2013 · AI
Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection$240,146
R43 · FY2008 · AI